Today we’ve got a teaser pitch from Marc Lichtenfeld to consider. It’s an ad for his Oxford Income Letter, but the “fountain of youth” pitch makes it sound like a wild ride of a biotech idea… so let’s dig in and see what we can find, shall we? Sometimes it’s best to start with the […]
Articles
10/28 update: this article is about a week old, but the teaser ads have changed a bit — the newsletter is now also being pitched under the headline, “Has this Maine town bottled the fountain of youth?” and it’s now also going out under the name Dr. Richard Robinson, who apparently works on the newsletter […]
Comments
The interview at the following site shows what rapamycin did for Dr. Alan S. Green. Whether that means that TORC will d...
NT Shudder. It bothers me to take anything, let alone Rapamycin, a pill that may lead to lymphoma. You never really know...
Fascinting article on CNN.com about Rapamycin, a drug manufactured by Pfizer: Developed first as an anti-fungal, used t...
Travis, I had two organ transplants in 2000 and I started taking Rapamycin as my anti-rejection after prograff gave me ...
Malis totalis. Rapamycin has been in clinical use for decades for solid organ transplant recipients. It'll cause you can...
The rapamycin - everolimus story is not all that new. I wrote about it in my aging piece in August. In mice, everoli...
John: none at present that I know of. Most forms of polycystic kidney disease are autosomal dominant, and this may make ...